Overview

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development...

Open

$0.00

Prior close

$120.39

Today's high

$0.00

Today's low

$0.00

52 Week high

$132.60

52 Week low

$89.25

News

24/7 Wall Street • 4 days ago • INCY

Buy, Sell, or Hold? Today's Top Upgrades and Downgrades: Boston Scientific, DoorDash, GE Vernova, Honeywell Aerospace, Incyte.

Seeking Alpha • 4 days ago • INCY

Incyte: Upgrading To Hold After ESMO Closed The Valuation Gap

Zacks Investment Research • 4 days ago • INCY

INCY Q3 Loss Narrower Than Expected, Sales Beat, FY'26 View Raised

Seeking Alpha • 4 days ago • INCY

Incyte Corporation (INCY) Q3 2026 Earnings Call Transcript

MarketBeat • 4 days ago • INCY

What Incyte (INCY) Said on Its Q3 Earnings Call